ArticleFrontiers in artificial intelligence2026
A multi-model prediction of a stage-specific prognosis for colorectal cancer using attention-driven deep ensemble learning on genomic profiling data.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Over the decades, shifts in human lifestyle have led to alterations in dietary habits. The consumption of diets low in fiber and high in fat and sugar results in the production of carcinogenic metabolites during digestion. The food we consume undergoes a complex series of processes involving digestion and excretion, engaging various internal organs within the human body. The DNA and MiRNA present in food are crucial for sustaining human health. Damage to human organs can lead to the development of cancer cells. Among various cancers, Colorectal Cancer (CRC) is the 3rd most common cancer that contributes to the increase in the mortality rate worldwide. Methods: One of the better ways for early CRC diagnosis is through Genomic Profiling. Frequent mutations in the genes APC, TP53, KRAS, PIK3CA, and SMAD4 are observed in the collected samples, contributing to CRC. An effort has been made in the proposed work to improve classification and prediction by using a deep ensemble learning approach based on a self-attention-based stacked bidirectional LSTM, optimized with the Parallel-Whale Optimization Algorithm (WOA) for global convergence, following a feature selection process. Furthermore, the survival analysis of CRC patients is performed using the DeepSurv technique to assess treatment effectiveness and patient care. Results: The performance of the proposed model is evaluated using various metrics for stage-based colorectal cancer prediction, and a comparative analysis is conducted to validate against benchmarking techniques, resulting in improved classification and prediction accuracy. Discussion: This study may help physicians detect CRC earlier and improve patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.